Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-20

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application from ANI Pharmaceuticals for fluvoxamine maleate, corresponding to a modification/expansion of the product's labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine (fluvoxamine)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)